Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Ono Pharmaceutical
Biotech
Ono inks deal for antibody against ‘very challenging’ I-O target
After seeing its partner’s work on a “new and very challenging immuno-oncology target,” Ono decided to commit to a $279 million financial package.
Nick Paul Taylor
Mar 31, 2022 7:58am
Vasella helps Numab to CHF22M round ahead of cancer trial start
Mar 9, 2020 7:00am
Ono pumps cash into U.K. immuno-oncology R&D effort
Mar 27, 2019 9:00am
Bristol-Myers boosts I-O offering with new Ono drug deal
Dec 14, 2017 5:05am
Array adds Ono as Japanese partner for MEK/BRAF combo
May 31, 2017 7:38am
Ono takes a long look at Seikagaku arthritis candidate
May 12, 2017 6:58am